Compare Hims and Hers Health Inc (HIMS) vs Procter & Gamble Co (PG) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Hims and Hers Health Inc vs Procter & Gamble Co — how do they compare? Hims and Hers Health Inc trades at $33.18 (market cap $7.57B), while Procter & Gamble Co trades at $147.8 (market cap $347.26B). The key difference: Procter & Gamble Co is far larger — about 45.9× Hims and Hers Health Inc's market cap, and Procter & Gamble Co pays a 2.92% dividend while Hims and Hers Health Inc pays none. Which is the better fit depends on your goals.
| HIMS | PG | |
|---|---|---|
Market Cap | $7.57B | $347.26B |
Sector | Health | Consumer Staples |
52-Week High | $66.18 | $167.18 |
52-Week Low | $14.52 | $138.10 |
Enterprise Value | $7.95B | $372.74B |
Volume | — | 6,423,436 |
Dividend Yield | — | 2.92% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Hims & Hers Health trades at $32.70, down 0.43% on the day, with a bearish technical signal despite bullish moving averages. The company reported $2.35 billion in 2025 revenue but swung to a projected net loss for 2026, with mixed quarterly earnings results. Recent news highlights executive changes and anticipation for Q2 2026 results on August 10, 2026, with analyst sentiment leaning toward a Buy consensus.
The outlook is cautious due to profitability concerns and high valuation multiples, but growth opportunities in weight-loss and telehealth services offer potential. Key risks include execution challenges and regulatory scrutiny. The stock presents a speculative growth play with a consensus price target of $33.57, slightly above the current price.
Procter & Gamble (PG) trades at $148.00, down 1.31% on the day, with a bullish technical signal from moving averages and neutral oscillators. The company reported consistent earnings beats in recent quarters, with Q2 2026 EPS expected at $1.41. Revenue reached $84.28 billion in 2025, with a net income margin of 19.16%. Recent developments include a partnership with the WNBA and ongoing dividend payments.
PG offers stable growth and reliable dividends, supported by strong cash flow and a 69-year dividend increase streak. Risks include premium valuation multiples and soft demand pressures. Analyst consensus is bullish with a $161.71 price target, suggesting potential upside from current levels amid moderate market volatility.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Hims and Hers Health Inc
Hims & Hers is a multi-specialty telehealth platform that provides personalized health and wellness products. It offers access to medical providers and treatments for hair loss, sexual health, and skincare.
Read more on HIMS →About Procter & Gamble Co
The Procter & Gamble Company manufactures and markets consumer products in countries throughout the world. The Company provides products in the laundry and cleaning, paper, beauty care, food and beverage, and health care segments. Procter & Gamble products are sold primarily through mass merchandisers, grocery stores, membership club stores, drug stores, and neighborhood stores.
Read more on PG →
